The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers
University of Medicine and Pharmacy at Ho Chi Minh City
300 participants
Dec 1, 2023
OBSERVATIONAL
Conditions
Summary
The goal of this clinical trial is to answer the research question whether hs Troponin I and NT-proBNP have a role in detecting atrial fibrillation in patients with pacemakers. Objectives of the study: 1. To survey some risk factors for atrial fibrillation in patients with permanent pacemakers. 2. To determine the role of hs Troponin I and NT-proBNP in predicting new-onset atrial fibrillation within follow-up time. 3. To build a model to predict the prognosis of atrial fibrillation based on the detected subclinical markers related to atrial fibrillation and classic cardiovascular risk factors.
Eligibility
Inclusion Criteria3
- Patient is an adult (≥ 18 years old or older)
- There is indication for permanent pacemaker placement and patient agreement to permanent pacemaker placement
- Patient agrees to participate in the study
Exclusion Criteria6
- Patients had a diagnosis of atrial fibrillation in their past history or atrial fibrillation is discovered at the time of participating in the study
- Severe patients, at risk of death
- Pregnant
- The patient is indicated for surgery
- Patients with eGFR ≤ 30 mL/min/1.73m2
- The patient has a serious infection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06174506